| Dr Seaborn M Hunt Iii, MD | |
|
3220 Sw 31st Rd, Suite 301, Ocala, FL 34474-7445 | |
| (352) 873-7200 | |
| (352) 873-7273 |
| Full Name | Dr Seaborn M Hunt Iii |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 28 Years |
| Location | 3220 Sw 31st Rd, Ocala, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700826922 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME76293 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Seaborn M Hunt Iii Md Pa | 3072780394 | 2 |
News Archive
The World Health Organization and the International Development Innovation Alliance today signed a strategic Collaborative Agreement to support the scaling of health innovations.
The current conflicts in Iraq and Afghanistan have resulted in extended and repeated combat-related deployments of U.S. military service members. While much has been reported about the problems, both physical and psychological, many bring back with them, new research out of UCLA shows that the family back home can have issues as well.
The fertile soil of California's Central Valley has long made it famous as one of the nation's prime crop-growing regions.
Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
› Verified 6 days ago
| Entity Name | Seaborn M Hunt Iii Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871863670 PECOS PAC ID: 3072780394 Enrollment ID: O20120126000669 |
News Archive
The World Health Organization and the International Development Innovation Alliance today signed a strategic Collaborative Agreement to support the scaling of health innovations.
The current conflicts in Iraq and Afghanistan have resulted in extended and repeated combat-related deployments of U.S. military service members. While much has been reported about the problems, both physical and psychological, many bring back with them, new research out of UCLA shows that the family back home can have issues as well.
The fertile soil of California's Central Valley has long made it famous as one of the nation's prime crop-growing regions.
Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Seaborn M Hunt Iii, MD 3220 Sw 31st Rd, Suite 301, Ocala, FL 34474-7445 Ph: (352) 873-7200 | Dr Seaborn M Hunt Iii, MD 3220 Sw 31st Rd, Suite 301, Ocala, FL 34474-7445 Ph: (352) 873-7200 |
News Archive
The World Health Organization and the International Development Innovation Alliance today signed a strategic Collaborative Agreement to support the scaling of health innovations.
The current conflicts in Iraq and Afghanistan have resulted in extended and repeated combat-related deployments of U.S. military service members. While much has been reported about the problems, both physical and psychological, many bring back with them, new research out of UCLA shows that the family back home can have issues as well.
The fertile soil of California's Central Valley has long made it famous as one of the nation's prime crop-growing regions.
Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
› Verified 6 days ago
Dr. Hina N Ahmed, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4414 Sw College Rd Ste 1462, Ocala, FL 34474 Phone: 352-622-5183 Fax: 352-629-5026 | |
Dr. James T Pizza, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2441 E Fort King St # 100, Ocala, FL 34471 Phone: 352-732-8404 | |
Dr. Gordon C. Schwenk, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1500 Se Magnolia Ext, Suite 106, Ocala, FL 34471 Phone: 352-622-5183 Fax: 352-622-1348 | |
Dr. Vishwanath Srinagesh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4414 Sw College Rd Ste 1462, Ocala, FL 34474 Phone: 352-622-5183 Fax: 352-629-5026 | |
Dr. Alethia Helen Pantazis, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2370 Se Laurel Run Dr, Ocala, FL 34471 Phone: 522-090-3003 | |
Isaac Samuel Vergara, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 60 Sw 17th St, Ocala, FL 34471 Phone: 352-482-0308 Fax: 524-820-3113 | |
H. Michael Morris, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4414 Sw College Rd Ste 1462, Ocala, FL 34474 Phone: 352-622-5183 Fax: 352-629-5026 |